Literature DB >> 2036746

Noncompartmental versus compartmental modelling in clinical pharmacokinetics.

W R Gillespie1.   

Abstract

Mesh：

Year:  1991        PMID： 2036746     DOI： 10.2165/00003088-199120040-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  19 in total

1.  Simple methods for estimation of mean residence time and steady-state volume of distribution from continuous-infusion data.

Authors:  W R Gillespie
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

Review 2.  Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part I).

Authors:  P Veng-Pedersen
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

3.  Theory of the mean absorption time, an adjunct to conventional bioavailability studies.

Authors:  D J Cutler
Journal:  J Pharm Pharmacol       Date:  1978-08       Impact factor: 3.765

4.  A system approach to pharmacodynamics. I: Theoretical framework.

Authors:  P Veng-Pedersen; W R Gillespie
Journal:  J Pharm Sci       Date:  1988-01       Impact factor: 3.534

5.  A linear recirculation model for drug disposition.

Authors:  D J Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

6.  A polyexponential deconvolution method. Evaluation of the "gastrointestinal bioavailability" and mean in vivo dissolution time of some ibuprofen dosage forms.

Authors:  W R Gillespie; P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1985-06

7.  Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerations.

Authors:  P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

8.  Numerical deconvolution by least squares: use of prescribed input functions.

Authors:  D J Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1978-06

9.  Deconvolution applied to the kinetics of extracorporal drug removal. Haemodialysis of cefsulodin.

Authors:  W R Gillespie; P Veng-Pedersen; T P Gibson
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

10.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12
View more
  13 in total

1.  Estimation of permanence time, exit time, dilution factor, and steady-state volume of distribution.

Authors:  J Mordenti; A Rescigno
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

2.  Pharmacokinetic analysis of mizolastine in healthy young volunteers after single oral and intravenous doses: noncompartmental approach and compartmental modeling.

Authors:  F Mesnil; C Dubruc; F Mentre; S Huet; A Mallet; J P Thenot
Journal:  J Pharmacokinet Biopharm       Date:  1997-04

3.  Analysis of pharmacokinetics of Gd-DTPA for dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Saeid Taheri; N Jon Shah; Gary A Rosenberg
Journal:  Magn Reson Imaging       Date:  2016-04-22       Impact factor: 2.546

4.  Reassessing models of hepatic extraction.

Authors:  D Ridgway; J A Tuszynski; Y K Tam
Journal:  J Biol Phys       Date:  2003-03       Impact factor: 1.365

Review 5.  Pharmacokinetic modeling of therapies for systemic lupus erythematosus.

Authors:  Xiaoyan Yang; Catherine M T Sherwin; Tian Yu; Venkata K Yellepeddi; Hermine I Brunner; Alexander A Vinks
Journal:  Expert Rev Clin Pharmacol       Date:  2015-07-09       Impact factor: 5.045

6.  Generalized pharmacokinetic modeling for drugs with nonlinear binding: I. Theoretical framework.

Authors:  W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1993-02

Review 7.  Clinical pharmacokinetics in veterinary medicine.

Authors:  J D Baggot
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

8.  Microencapsulation Approach for Orally Extended Delivery of Glipizide: In vitro and in vivo Evaluation.

Authors:  A Abdelbary; N A El-Gendy; A Hosny
Journal:  Indian J Pharm Sci       Date:  2012-07       Impact factor: 0.975

Review 9.  The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics.

Authors:  J G Coen van Hasselt; Marilee A Andrew; Mary F Hebert; Joel Tarning; Paolo Vicini; Donald R Mattison
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

10.  Influence of hepatic regeneration after partial hepatectomy on theophylline pharmacokinetics in rats.

Authors:  A M Maza; A R Gascon; R M Hernandez; M A Solinis; M B Calvo; J L Pedraz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jan-Jun       Impact factor: 2.569
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.